Application of High-Throughput, Molecular-Targeted Screening to Anticancer Drug Discovery

Author(s): Robert H. Shoemaker, Dominic A. Scudiero, Giovanni Melillo, Michael J. Currens, Anne P. Monks, Alfred A. Rabow, David G. Covell, Edward A. Sausville.

Journal Name: Current Topics in Medicinal Chemistry

Volume 2 , Issue 3 , 2002

Become EABM
Become Reviewer


Increasing insight into the genetics and molecular biology of cancer has resulted in the identification of an increasing number of potential molecular targets for anti-cancer drug discovery and development. These targets can be approached through exploitation of emerging structural biology,”rational“ drug design, screening of chemical libraries, or a combination of these methods. In this article we discuss the application of high-throughput screening to anti-cancer drug discovery, with special reference to approaches used at the U.S. National Cancer Institute.

Keywords: anticancer drug discovery, molecular medicine, (cat) assays

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [229 - 246]
Pages: 18
DOI: 10.2174/1568026023394317
Price: $58

Article Metrics

PDF: 9